Format

Send to

Choose Destination
J Antimicrob Chemother. 2009 Apr;63(4):709-12. doi: 10.1093/jac/dkn551. Epub 2009 Jan 31.

In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.

Author information

1
Division of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.

Abstract

OBJECTIVES:

To compare the antimicrobial activity of tigecycline and doxycycline against multiple isolates of Borrelia burgdorferi.

METHODS:

In vitro antimicrobial assays were carried out using a microdilution assay. The time needed to inhibit, immobilize and kill the B31 strain of B. burgdorferi was determined. The MIC, MBC and concentration needed to immobilize the organism were determined for each antimicrobial for various strains of B. burgdorferi.

RESULTS:

Tigecycline inhibited the growth of and killed the organism more rapidly than doxycycline. Tigecycline was able to kill B. burgdorferi within 24 h at clinically achievable concentrations (<1 mg/L). In contrast, doxycycline was bacteriostatic and required 48-72 h to achieve its maximal inhibitory effect. The anti-Borrelia activity of the antibiotics was tested against 20 different isolates from three species. Tigecycline was 16- to 1000-fold more active than doxycycline at immobilizing Borrelia for the 20 isolates tested.

CONCLUSIONS:

We demonstrate that the in vitro activity of tigecycline against B. burgdorferi is superior to that of doxycycline. Tigecycline acted more rapidly and was bactericidal, whereas doxycycline was bacteriostatic and required a more prolonged co-incubation to achieve its maximal inhibitory effect.

PMID:
19182236
DOI:
10.1093/jac/dkn551
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center